Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

drug-trials

University of Birmingham scientists develop new MRI contrast agent

November 12, 2025 Research and Development Diagnostics, MRI, University of Birmingham, medical imaging

Researchers at the University of Birmingham, UK, have developed a new class of magnetic resonance imaging (MRI) contrast agents that …
News

Novartis receives SMC approval for early breast cancer treatment

November 11, 2025 Research and Development Novartis, Scottish Medicines Consortium, breast cancer, nhs scotland

Novartis has announced that its treatment for early breast cancer, Kisqali (ribociclib), has received approval for use within NHS Scotland …
News

Vesper Bio reports positive topline results for dementia candidate

November 7, 2025 Research and Development Frontotemporal degeneration, Vesper Bio, clinical trials, dementia

Vesper Bio, a clinical-stage biotech developing novel oral therapies for neurodegenerative and neuropsychiatric disorders, has reported positive topline data from …
News

AAX Biotech and ToxoTech partner to develop next-gen biotherapeutics for neurological disorders

November 7, 2025 Research and Development AAX Biotech, Biotherapeutics, ToxoTech, neurological disorders

AAX Biotech, a biotech company specialising in next-generation antibody therapeutics, has entered a strategic partnership with ToxoTech, a biopharma company …
News

Von Willebrand disease – increasing awareness and access to vital care

November 4, 2025 Medical Communications, Research and Development European Medicines Association, Haematology, Takeda, Von Willebrand Disease, clinical trials, disease awareness

Pharmafile talks to Anthea Cherednichenko, Vice President Franchise Head Haematology and Transplant at Takeda about Von Willebrand disease, its causes …
Feature

Rethinking oncology trial endpoints with generalised pairwise comparisons

November 4, 2025 Research and Development EMA, FDA, Oncology, One2Treat, clinical trials, generalised pairwise comparisons, net treatment benefit, oncology

For decades, oncology trials have been anchored to a familiar set of endpoints. Overall survival (OS) and progression-free survival (PFS) …
Feature

The Pharma Files: with Dr Ewen Cameron, Chief Executive of West Suffolk NHS Foundation Trust

November 3, 2025 Medical Communications, Research and Development Corporate, NHS, The Pharma Files, healthcare professionals, patient care, patients

Pharmafile chats with Dr Ewen Cameron, Chief Executive of West Suffolk NHS Foundation Trust, about the best parts of his …
Feature
partnership

Landmark Bio and Mass General Brigham partner to accelerate translational CGT therapies

October 30, 2025 Research and Development Landmark Bio, Mass General Brigham, cell and gene therapies, partnership

Landmark Bio and Mass General Brigham in the US have entered a new strategic collaboration designed to accelerate the development …
News

BioMedX launches R&D accelerator to advance women’s health

October 28, 2025 Research and Development BioMedX, Gates Foundation, Women’s Health

BioMed X, an independent research institute with sites in Germany and the United States, has announced the launch of XFem …
News
drug-trials

THX Pharma and Exeltis announce first milestone achieved for neurological disease treatment

October 23, 2025 Research and Development Neurological Diseases, THX Pharma, Theranexus

THX Pharma (Theranexus), a pharma company focusing on developing treatments for rare neurological disease, and Exeltis, a pharma company within …
News

Chemify relocates to Glasgow’s new Health Innovation Hub

October 17, 2025 Research and Development Chemify, Kadans Science Partner, Scotland

The company will be one of the first tenants in the city’s flagship life sciences facility
News

Oxford North UK innovation district officially opened

October 16, 2025 Research and Development Oxford North, University of Oxford, innovation district

Oxford North, a new innovation district in Oxford, UK, with planning permission for around one million sq ft of newly …
News

Symeres appoints Gabriella Gentile as chief operating officer

October 13, 2025 Research and Development Symeres

Symeres, a mid-sized contract research, development and manufacturing organisation (CRDMO), has appointed Gabriella Gentile as its chief operating officer. Operating …
Appointment

Uterine fibroids and the cost of silence

October 9, 2025 Medical Communications, Research and Development Reproductive health, gynaecological conditions, menstruation, uterine fibroids

By Tina Backhouse Stigma and shame Every month, most women on the planet have a period. It’s completely natural – …
Feature

Recipharm designates Germany site as Centre of Excellence

October 9, 2025 Research and Development CDMO, Cuxhaven, Recipharm, biologics

The multi-product facility recently underwent significant renovations
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026